News

Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, has invested in additional equipment to enhance capacity in early phase drug development. Another Xcelodose® 600S precision powder micro-dosing system will further provide capacity and efficiency...

The Ashfield Excellence Academy has been formed to design, develop and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries. The Academy sits within Ashfield Engage, a business unit of Ashfield, part of UDG Healthcare. Previously...

Pharmapack Europe (#PharmapackEU) announce the winners of the 2021 Pharmapack Awards and, due to the exceptional quality of this year’s entries, seven winners have been chosen across both the ‘Exhibitor Innovation’ and ‘Health Product’ awards. The Exhibitor Innovation awards recognise...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has set out plans to respond to the changing needs of the life science industry as digital transformation accelerates. The Alliance will reorganise...

Merck has submitted an emergency use authorization (EUA) application to the US Food and Drug Administration (FDA) for its investigational oral antiviral medicine, molnupiravir (MK-4482/EIDD-2801), to treat Covid-19. Being developed in collaboration with Ridgeback Biotherapeutics, molnupiravir is an investigational, orally-administered...

Chugai Pharmaceutical Co., Ltd. announced that it filed an application with the Ministry of Health, Labour and Welfare (MHLW) for approval of additional indications for the anti-SARS-CoV-2 monoclonal antibody RONAPREVE for prophylaxis of COVID-19 and treatment of asymptomatic...

The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of...